Melatonin for cognitive impairment (Protocol)

• Author(s) / Creator(s)

  • Forbes, D.
  • Morgan, D.G.
  • Jansen, S.L.
  • Duncan, V.

• This is the protocol for a review and there is no abstract. The objectives are as follows: The primary objective is a systematic review of evidence relating to the clinical efficacy and safety of melatonin in the treatment of manifestations of dementia or cognitive impairment (CI).

• Date created

  2005

• Subjects / Keywords

  • Cognitive impairment
  • Melatonin

• Type of Item

  Article (Published)

• DOI

  https://doi.org/10.7939/R30C4SR9W

• License

  © 2005 The Cochrane Collaboration for John Wiley & Sons, Ltd. This version of this article is open access and can be downloaded and shared. The original author(s) and source must be cited.